产品编号 :
Cas No. :
CAS No. |
3004676-77-8 |
|---|---|
中文名称 |
1-(4'-((5-环丙基-3-(2,6-二氯苯基)异噁唑-4-基)甲氧基)-[1,1'-联苯]-3-基)环丙烷-1-羧酸 |
英文名称 |
1-(4'-((5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-[1,1'-biphenyl]-3-yl)cyclopropane-1-carboxylic acid |
别名 |
ZLY28;Cyclopropanecarboxylic acid, 1-[4′-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy][1,1′-biphenyl]-3-yl]- |
标准英文名 |
1-(4'-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)-[1,1'-biphenyl]-3-yl)cyclopropane-1-carboxylic acid |
分子式 |
C29H23Cl2NO4 |
分子量 |
520.41 |
精确分子量 |
519.10 |
SMILES |
OC(C1(C2=CC=CC(C3=CC=C(C=C3)OCC4=C(ON=C4C5=C(C=CC=C5Cl)Cl)C6CC6)=C2)CC1)=O |
标准SMILES |
OC(=O)C1(CC1)C1=CC=CC(=C1)C1=CC=C(C=C1)OCC1C(=NOC=1C1CC1)C1=C(Cl)C=CC=C1Cl |
用途 |
ZLY28 is a first-in-class gut-restricted dual modulator of FXR and FABP1 with oral activity; it is a novel anti-NASH agent and can be used in the study of non-alcoholic steatohepatitis (NASH). |
InChIKey |
GFQRXOXNBQDNBC-UHFFFAOYSA-N |
|
|
评论 |
|---|